Roemmers Group continues strengthening its presence in Central America through a new expansion project in El Salvador led by Laboratorio Siegfried and Laboratorio Pharmedic.
According to information shared by Rodrigo Ayala, the investment will exceed $5.1 million and forms part of the company’s strategy to reinforce operations in the Central American and Caribbean markets.
The expansion reflects growing confidence from international companies in El Salvador’s economic environment and industrial development. Authorities have highlighted that investments in strategic sectors such as pharmaceuticals contribute to job creation, technological modernization, and regional competitiveness.
Siegfried Corporation, part of Argentina-based Roemmers Group, has maintained operations in El Salvador for years and continues positioning the country as an important hub for healthcare and pharmaceutical production in the region.
Observers note that El Salvador has increasingly attracted foreign investment projects tied to manufacturing, logistics, technology, and healthcare industries amid ongoing economic transformation efforts promoted by President Nayib Bukele’s administration.